REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Regeneron Therapeutics, Inc. to Contact the Firm Today!
Portfolio Pulse from
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. for alleged violations of federal securities laws. The lawsuit targets those who acquired Regeneron securities between November 2, 2023, and October 30, 2024.
March 05, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a class action lawsuit for alleged violations of federal securities laws, potentially impacting its stock price.
The lawsuit could lead to financial penalties or settlements, which may negatively impact Regeneron's stock price. Legal issues often create uncertainty, leading to potential short-term price declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100